Including the chemical structure of the compound and the company's plans for its manufacture in the IND helps the FDA assess:
A) The company's projected annual profits.
B) Whether the company can produce sufficient quantities of the drug.
C) Whether the company can produce and supply consistent batches of the drug.
D) How long it will be before a generic equivalent can come to market.
C
You might also like to view...
An option to the administration of 50 percent dextrose in the unconscious patient without a suitable intravenous site is:
A) dextrose 25 percent IM. B) insulin SQ. C) glucagon IM. D) insulin IV.
All of the following are true statements regarding the biohazard label except:
A) the label is fluorescent orange or red in color. B) the label must be displayed on refrigerators used to store blood, blood products, OPIM, and body fluids. C) clear plastic bags may be used in place of the biohazard label. D) the label must be secured to all containers that hold contaminated materials.